What is the primary reason for monitoring the complete blood count (CBC) in a patient with acute lymphoblastic leukemia?

D) To identify anemia and thrombocytopenia

B) To evaluate nutritional status

D) To identify anemia and thrombocytopenia

A patient diagnosed with acute lymphoblastic leukemia presents with a hemoglobin level of 8.5 g/dL and a platelet count of 45,000/µL. Which nursing intervention is most appropriate to address these lab findings?

B) Implement bleeding precautions due to thrombocytopenia

A) Encourage the patient to engage in physical exercise to boost hemoglobin levels

B) Implement bleeding precautions due to thrombocytopenia

C) Administer oxygen therapy to improve white blood cell function

D) Restrict fluid intake to prevent fluid overload

A patient with newly diagnosed acute lymphoblastic leukemia has a low hemoglobin level and a low platelet count. Which of the following nursing interventions is most important to prioritize?

C) Monitor the patient for signs of bleeding and prepare for possible transfusions

A) Encourage the patient to ambulate frequently to prevent deep vein thrombosis

B) Educate the patient and family about the importance of infection prevention

C) Monitor the patient for signs of bleeding and prepare for possible transfusions

D) Provide a high-protein diet to improve immune function

In caring for a 10-year-old patient undergoing chemotherapy, which of the following nursing interventions is most important to prevent complications related to thrombocytopenia?

B) Implement fall precautions to prevent injury

A) Encourage increased fluid intake to maintain hydration

B) Implement fall precautions to prevent injury

C) Monitor vital signs every 4 hours

D) Administer antiemetics as prescribed to manage nausea

A 10-year-old patient receiving chemotherapy is experiencing thrombocytopenia with a platelet count of 40,000/µL. Which nursing intervention is most appropriate to reduce the risk of bleeding?

B) Use a soft-bristled toothbrush for oral hygiene

A) Encourage the patient to participate in contact sports

B) Use a soft-bristled toothbrush for oral hygiene

C) Administer aspirin for mild pain relief

D) Perform frequent invasive procedures to monitor lab values

What is the primary reason for administering a packed red blood cell transfusion to this child undergoing chemotherapy?

B) To improve energy levels by addressing anemia.

A) To increase white blood cell count.

B) To improve energy levels by addressing anemia.

What is the primary reason for administering a red blood cell transfusion to the patient in this scenario?

B) To address the patient's anemia and improve energy levels

A) To increase the patient's platelet count

B) To address the patient's anemia and improve energy levels

C) To reduce the patient's risk of infection

D) To decrease the patient's white blood cell count

What is the most important home care instruction for the boy's family to prevent complications associated with thrombocytopenia?

B) Advise using a soft toothbrush for oral hygiene.

A) Encourage the boy to drink more fluids.

B) Advise using a soft toothbrush for oral hygiene.

C) Ensure the boy participates in regular physical activities.

D) Provide the boy with a high-protein diet.

What is the primary reason for advising the family to use a soft toothbrush for the child undergoing chemotherapy?

A) To prevent gum irritation and bleeding

B) To improve the child's dental hygiene

C) To ensure the child brushes for the recommended time

D) To encourage the child to brush more frequently

Acute lymphoblastic leukemia - Nursing Case Study

Pathophysiology

• Primary mechanism: Acute lymphoblastic leukemia (ALL) is caused by the overproduction of immature white blood cells, called lymphoblasts, in the bone marrow. This overcrowding prevents the normal production of healthy blood cells, leading to symptoms like anemia, infection, and bleeding.

• Secondary mechanism: Genetic mutations and chromosomal abnormalities in lymphoid progenitor cells drive the uncontrolled proliferation of these immature cells, contributing to the development of ALL. These mutations disrupt normal cell cycle regulation and apoptosis.

• Key complication: Due to the high number of lymphoblasts, patients may experience bone pain and an enlarged spleen or liver, as the body struggles to accommodate the excess cells, leading to further clinical complications.

Patient Profile

Demographics:

12-year-old male, student

History:

• Key past medical history: No significant past medical history

• Current medications: None

• Allergies: None known

Current Presentation:

• Chief complaint: Fatigue and easy bruising

• Key symptoms: Mild fatigue, petechiae on arms and legs, occasional nosebleeds

• Vital signs: Temperature 98.6°F, Heart Rate 80 bpm, Blood Pressure 110/70 mmHg, Respiratory Rate 18 breaths per minute

Section 1

Initial Assessment Findings:

Upon conducting a comprehensive physical assessment, the nurse notes that the 12-year-old male presents with pallor, which is consistent with his reported fatigue and may suggest anemia. The petechiae observed on his arms and legs are indicative of thrombocytopenia, a common finding in patients with acute lymphoblastic leukemia due to the overcrowding of lymphoblasts in the bone marrow. The nurse assesses for additional signs of bleeding, such as gum bleeding or prolonged bleeding from minor cuts, but none are noted at this time. The occasional nosebleeds reported by the patient are documented and are likely related to the low platelet count.

The nurse also palpates the abdomen for any signs of organomegaly. Mild splenomegaly is detected, which aligns with the known complication of an enlarged spleen due to the accumulation of abnormal cells. The patient denies any significant bone pain at present, and his vital signs remain stable with a temperature of 98.6°F, heart rate of 80 bpm, blood pressure of 110/70 mmHg, and respiratory rate of 18 breaths per minute. These findings suggest that while the patient is stable, he is at risk for further complications related to his condition.

Based on these assessment findings, the healthcare team is prompted to prioritize interventions that address the patient's anemia and thrombocytopenia. This includes monitoring the complete blood count (CBC) results closely to determine the need for potential blood transfusions or platelet administration. Education is also provided to the patient and family regarding signs and symptoms of bleeding and infection, emphasizing the importance of promptly reporting any changes. As the team continues to monitor the patient, they prepare for further diagnostic evaluations to better understand the progression of his acute lymphoblastic leukemia and tailor his treatment plan accordingly.

Section 2

New Diagnostic Results:

Following the initial assessment, the healthcare team proceeds with additional diagnostic evaluations to gain a clearer understanding of the patient’s condition. The results of the complete blood count (CBC) confirm the presence of anemia, with a hemoglobin level of 8.5 g/dL, and thrombocytopenia, as indicated by a platelet count of 45,000/µL. The white blood cell (WBC) count is elevated at 15,000/µL, reflecting the presence of immature lymphoblasts. These findings are consistent with the diagnosis of acute lymphoblastic leukemia and underscore the need for ongoing monitoring and potential therapeutic interventions.

The team also conducts a bone marrow aspiration, which reveals a high percentage of lymphoblasts, confirming the diagnosis of early-stage acute lymphoblastic leukemia. The cytogenetic analysis does not show any high-risk chromosomal abnormalities, which is a positive prognostic indicator and suggests a more favorable response to standard treatment protocols. With these results, the healthcare team discusses the importance of initiating chemotherapy to target the leukemic cells and prevent further complications.

In light of these diagnostic findings, the healthcare team schedules a family meeting to discuss the treatment plan, including the expected side effects of chemotherapy and the importance of supportive care measures. The nurse emphasizes the need for regular monitoring of blood counts and the potential requirement for transfusions to manage anemia and thrombocytopenia. Education on infection prevention and vigilant observation for any signs of bleeding becomes a focal point, ensuring the family is well-informed and prepared to participate actively in the patient's care. This collaborative approach aims to support the patient and family through the initial phases of treatment, setting the stage for the next steps in managing his acute lymphoblastic leukemia.

Section 3

Following the initiation of chemotherapy, the patient, a 10-year-old boy, is closely monitored for his response to the intervention. Over the first week, his vital signs remain stable with a temperature of 98.6°F, heart rate of 88 beats per minute, and blood pressure of 110/70 mmHg. The patient experiences mild fatigue, which is expected due to both his anemia and the effects of chemotherapy. During routine assessments, the nurse notes slight pallor and mild bruising on the patient's arms, which are consistent with his thrombocytopenia.

Laboratory results show mild improvements in the white blood cell count, which decreases to 12,000/µL, indicating an initial positive response to the chemotherapy. However, the patient's hemoglobin remains low at 8.2 g/dL, and his platelet count has dropped further to 40,000/µL. These findings necessitate a more focused supportive care strategy, including the potential need for a transfusion of both packed red blood cells and platelets to mitigate the risk of bleeding and further anemia.

The healthcare team discusses these findings with the family, reiterating the importance of maintaining vigilance for any signs of infection, such as fever or unusual fatigue, given the patient's immunocompromised status. The nurse provides education on the importance of a balanced diet to support energy levels and the body's ability to heal, as well as strategies to manage fatigue, such as rest periods and light activity. As the treatment progresses, ongoing assessments will be crucial to evaluate the patient's tolerance to chemotherapy and to adjust the care plan as necessary, ensuring optimal support through this critical phase.

Section 4

As the second week of chemotherapy begins, the nurse conducts another routine assessment of the patient. The 10-year-old boy continues to exhibit mild fatigue, but his vital signs remain stable with a temperature of 98.4°F, heart rate of 90 beats per minute, and blood pressure of 108/68 mmHg. Notably, the nurse observes a slight decrease in the bruising on his arms, suggesting a potential stabilization of his platelet levels. The child's appetite has slightly improved, and he is engaging more in light activities, such as drawing and playing board games, indicating effective management of his fatigue.

New laboratory results show a further decrease in the white blood cell count to 9,000/µL, which is approaching a normal range and suggests a continuing positive response to chemotherapy. However, his hemoglobin remains low at 7.9 g/dL, and his platelet count is still concerning at 38,000/µL. Based on these results, the healthcare team decides to proceed with a transfusion of packed red blood cells to address the anemia and improve his energy levels. The team also reinforces education with the family about signs of bleeding, such as petechiae or bleeding gums, given the persistent thrombocytopenia.

Following the red blood cell transfusion, the boy reports feeling slightly more energetic, and his skin appears less pallid. The nurse will continue to monitor his response to the transfusion closely, noting any changes in his energy levels and overall well-being. The healthcare team remains vigilant in assessing the risk of infection and is prepared to adjust the care plan as necessary, ensuring that the patient receives comprehensive support throughout his treatment journey. This proactive approach aims to maintain the stability of his condition and facilitate his recovery as he progresses through his therapy.

Section 5

As the boy enters the third week of chemotherapy, the nurse conducts another routine assessment. The child’s vital signs remain stable, with a temperature of 98.6°F, heart rate of 88 beats per minute, and blood pressure of 106/70 mmHg. His energy levels have improved slightly since the red blood cell transfusion, and he is participating more actively in play and schoolwork. The nurse notes that his mucous membranes are pinker, and his skin continues to show fewer signs of bruising, suggesting some stabilization of his platelet count. However, the nurse observes that the boy has developed occasional nosebleeds, which are mild but warrant attention given his low platelet levels.

New laboratory results indicate a slight improvement in his hemoglobin, now at 8.3 g/dL, reflecting a positive response to the transfusion. His platelet count has modestly increased to 42,000/µL, yet still demands careful monitoring. The white blood cell count remains stable at 8,500/µL, demonstrating ongoing responsiveness to treatment. The healthcare team decides to provide additional education to the family on managing and preventing potential complications from thrombocytopenia at home. They emphasize the importance of avoiding contact sports and using a soft toothbrush to minimize the risk of bleeding.

In response to these findings, the healthcare team continues to focus on supportive care, closely monitoring for signs of infection due to the boy’s still-compromised immune system. The team also addresses the child's nutritional needs to support his recovery, encouraging a balanced diet rich in iron and vitamins. The nurse arranges a follow-up with the pediatric oncology team to evaluate the current treatment regimen and discuss any necessary adjustments, ensuring the boy remains on track for recovery while minimizing potential complications.